Literature DB >> 30033779

Health benefits of Mediterranean diet in nonalcoholic fatty liver disease.

Ludovico Abenavoli1, Laura Di Renzo2, Luigi Boccuto3, Nuha Alwardat2, Santo Gratteri4, Antonino De Lorenzo2.   

Abstract

INTRODUCTION: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Insulin resistance and obesity-related inflammatory status, associated with genetic, dietary, and lifestyle factors, are involved in its pathogenesis. There is no consensus concerning the pharmacological treatment of NAFLD. However, the international guidelines agree to define a dietetic nutritional management to achieve weight loss, as an essential component of any therapeutic strategy. Areas covered: An overview on the beneficial effects of the Mediterranean diet in the prevention and treatment of NAFLD. Expert commentary: On the basis of its components, the literature reports the beneficial effects of the Mediterranean diet in preventing major chronic diseases, including obesity, diabetes, cardiovascular diseases, and some forms of cancers. In recent years, a growing body of evidence has supported the idea that the Mediterranean diet, associated with physical activity and cognitive behavior therapy, may be the reference nutritional profile for the prevention and the treatment of NAFLD patients.

Entities:  

Keywords:  Food; Nicotera; inflammation; metabolism; microbiota; obesity

Mesh:

Year:  2018        PMID: 30033779     DOI: 10.1080/17474124.2018.1503947

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  13 in total

1.  Is possible to detect nonalcoholic fatty liver disease by a new index including single nucleotide polymorphisms (SNPs)?

Authors:  Ludovico Abenavoli; Luigi Boccuto
Journal:  Ann Transl Med       Date:  2018-09

Review 2.  Mediterranean Diet and Obesity-related Disorders: What is the Evidence?

Authors:  Giovanna Muscogiuri; Ludovica Verde; Cem Sulu; Niki Katsiki; Maria Hassapidou; Evelyn Frias-Toral; Gabriela Cucalón; Agnieszka Pazderska; Volkan Demirhan Yumuk; Annamaria Colao; Luigi Barrea
Journal:  Curr Obes Rep       Date:  2022-09-30

Review 3.  Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.

Authors:  Renyi Su; Xuyong Wei; Qiang Wei; Di Lu; Zuyuan Lin; Shuo Wang; Chuxiao Shao; Xiao Xu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

Review 4.  The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).

Authors:  Zahra Safari; Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.207

5.  Cardiovascular Health Metrics in the Development and Regression of Nonalcoholic Fatty Liver Disease: A Cohort Study.

Authors:  Eun-Hee Jang; Yoosoo Chang; Seungho Ryu; Seolhye Kim; Young Hwan Kim; Ki-Chul Sung; Yong Kyun Cho; Soo-Jin Lee; Hocheol Shin; Sarah H Wild; Christopher D Byrne
Journal:  J Clin Med       Date:  2019-05-06       Impact factor: 4.241

6.  Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling.

Authors:  Yin Yao
Journal:  Mol Med Rep       Date:  2020-01-13       Impact factor: 2.952

Review 7.  Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way.

Authors:  Ludovico Abenavoli; Luigi Boccuto; Alessandro Federico; Marcello Dallio; Carmelina Loguercio; Laura Di Renzo; Antonino De Lorenzo
Journal:  Int J Environ Res Public Health       Date:  2019-08-21       Impact factor: 3.390

Review 8.  Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review.

Authors:  Paul Brennan; Kathleen Clare; Jacob George; John F Dillon
Journal:  World J Gastroenterol       Date:  2020-04-21       Impact factor: 5.742

9.  The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Ewa Stachowska; Piero Portincasa; Dominika Jamioł-Milc; Dominika Maciejewska-Markiewicz; Karolina Skonieczna-Żydecka
Journal:  Nutrients       Date:  2020-11-11       Impact factor: 5.717

Review 10.  Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in C57bl/6 Models.

Authors:  Leonardo Recena Aydos; Luane Aparecida do Amaral; Roberta Serafim de Souza; Ana Cristina Jacobowski; Elisvânia Freitas Dos Santos; Maria Lígia Rodrigues Macedo
Journal:  Nutrients       Date:  2019-12-16       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.